| Dr Lindsey George, OD | |
|
2111 Tiger Town Pkwy, Opelika, AL 36801-5487 | |
| (334) 528-9020 | |
| Not Available |
| Full Name | Dr Lindsey George |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 3 Years |
| Location | 2111 Tiger Town Pkwy, Opelika, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174191720 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT003335 (Georgia) | Secondary |
| 152W00000X | Optometrist | 2823 (Arkansas) | Secondary |
| 152W00000X | Optometrist | S-E82 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Parmelee Eye Care Llc | 9830498435 | 4 |
News Archive
Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
Researchers say that oral anticoagulation could improve the prognosis of atrial fibrillation patients who undergo percutaneous coronary intervention, even if they have a high bleeding risk according to the HAS-BLED score.
GenePeeks, Inc., a genetic technology company focused on pre-conception risk prediction, announced today it has been issued patent No. 8,620,594, titled "Method and System for Generating a Virtual Progeny Genome," by the United States Patent and Trademark Office.
Study evidence supports a link between thiazolidinedione use, particularly pioglitazone, and bladder cancer in patients with Type 2 diabetes, Canadian researchers report.
› Verified 1 days ago
| Provider Name | Parmelee Eye Care Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1447618525 PECOS PAC ID: 9830498435 Enrollment ID: O20160503002475 |
News Archive
Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
Researchers say that oral anticoagulation could improve the prognosis of atrial fibrillation patients who undergo percutaneous coronary intervention, even if they have a high bleeding risk according to the HAS-BLED score.
GenePeeks, Inc., a genetic technology company focused on pre-conception risk prediction, announced today it has been issued patent No. 8,620,594, titled "Method and System for Generating a Virtual Progeny Genome," by the United States Patent and Trademark Office.
Study evidence supports a link between thiazolidinedione use, particularly pioglitazone, and bladder cancer in patients with Type 2 diabetes, Canadian researchers report.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lindsey George, OD 19 Cotton Ct, Fort Mitchell, AL 36856-5415 Ph: (870) 291-2663 | Dr Lindsey George, OD 2111 Tiger Town Pkwy, Opelika, AL 36801-5487 Ph: (334) 528-9020 |
News Archive
Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
Researchers say that oral anticoagulation could improve the prognosis of atrial fibrillation patients who undergo percutaneous coronary intervention, even if they have a high bleeding risk according to the HAS-BLED score.
GenePeeks, Inc., a genetic technology company focused on pre-conception risk prediction, announced today it has been issued patent No. 8,620,594, titled "Method and System for Generating a Virtual Progeny Genome," by the United States Patent and Trademark Office.
Study evidence supports a link between thiazolidinedione use, particularly pioglitazone, and bladder cancer in patients with Type 2 diabetes, Canadian researchers report.
› Verified 1 days ago
Eamc Eye Clinic, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 122 N 20th St Bldg 26, Opelika, AL 36801 Phone: 334-749-1486 | |
Dr. Charles Kennon Berry Sr., O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2900 Pepperell Parkway, Vision Center Store 0355, Opelika, AL 36801 Phone: 334-745-0980 Fax: 334-745-6211 | |
Whatley Eye Care, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 518 Avenue A, Opelika, AL 36801 Phone: 334-745-3112 Fax: 334-745-8751 | |
The Optical Shop Optometrist Medicare: Medicare Enrolled Practice Location: 2496 Enterprise Dr, Opelika, AL 36801 Phone: 334-705-8803 | |
Whatley Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 518 Avenue A, Opelika, AL 36801 Phone: 334-745-3112 Fax: 334-745-8751 | |
Auburn Lasik & Eye Institute, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 3021 Frederick Rd, Ste 4, Opelika, AL 36801 Phone: 334-705-8803 Fax: 334-705-8643 |